Literature DB >> 15981027

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity.

Salih Ozgocmen1, Serpil Bulut, Nevin Ilhan, Arif Gulkesen, Ozge Ardicoglu, Yusuf Ozkan.   

Abstract

Multiple sclerosis (MS) is a chronic disease and a major cause of disability in young adults. The aims of this study were to assess bone mass in patients with MS in comparison to healthy age- and sex-matched controls, and to evaluate factors influencing bone mineral density (BMD), and the relationship of the pain threshold at peripheral and axial sites with BMD in MS. Thirty-one patients with MS and 30 matched healthy controls participated in the study. The Kurtzke expanded disability status scale (EDSS) and the functional independence measure (FIM) were used to scale disability, mobility, and functional status. Serum 25(OH) vitamin D levels were measured. BMD was measured using dual X-ray absorptiometry (DXA). MS patients had significantly lower BMD at the lumbar spine (L2-L4) and femur trochanter compared to the matched controls. BMD of the lumbar spine was nearly 1 SD lower in MS patients compared with the healthy reference population (Z scores). MS patients had significantly lower vitamin D levels (17.3 ng/ml vs 43.1 ng/ml; P < 0.001) compared to controls, and 19 patients (61%) had a serum level of vitamin D that was less than 20 ng/ml. EDSS scores in the patients were inversely correlated with proximal femur BMD but not with spinal BMD. There was a negative correlation with the cumulative steroid dose and BMD only for femur trochanter BMD. Total myalgia scores for paravertebral muscles correlated significantly with spinal BMD. In conclusion, BMD is significantly lower in MS patients than in healthy controls, vitamin D deficiency is prevalent in MS, and ambulatory status is a determinative factor for osteoporosis in MS. Patients should be encouraged to have adequate sunlight exposure and to increase their mobility. Specific strengthening exercises for hip and back muscles in MS patients would have a substantial impact on bone density, osteoporosis, fracture risk, and mobility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981027     DOI: 10.1007/s00774-005-0604-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  19 in total

Review 1.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  Adaptation of the Functional Independence Measure for use in Turkey.

Authors:  A A Küçükdeveci; G Yavuzer; A H Elhan; B Sonel; A Tennant
Journal:  Clin Rehabil       Date:  2001-06       Impact factor: 3.477

3.  Vitamin D deficiency: what a pain it is.

Authors:  Michael F Holick
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

4.  Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis.

Authors:  S R Schwid; A D Goodman; J E Puzas; M P McDermott; D H Mattson
Journal:  Arch Neurol       Date:  1996-08

5.  Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients.

Authors:  Yoshihiro Sato; Norifumi Metoki; Jun Iwamoto; Kei Satoh
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

6.  Osteoporosis after spinal cord injury.

Authors:  G Demirel; H Yilmaz; N Paker; S Onel
Journal:  Spinal Cord       Date:  1998-12       Impact factor: 2.772

7.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis.

Authors:  J Nieves; F Cosman; J Herbert; V Shen; R Lindsay
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

8.  What affects your MS? Responses to an anonymous, Internet-based epidemiological survey.

Authors:  Rex D Simmons; Anne-Louise Ponsonby; Ingrid A F van der Mei; Peter Sheridan
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

9.  Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy.

Authors:  Ali Gür; Aziz Denli; Kemal Nas; Remzi Cevik; Mehmet Karakoc; Aysegul Jale Sarac; Ferda Erdogan
Journal:  Rheumatol Int       Date:  2002-07-10       Impact factor: 2.631

10.  Bone mineral content of the lumbar spine and lower extremities years after spinal cord lesion.

Authors:  F Biering-Sørensen; H Bohr; O Schaadt
Journal:  Paraplegia       Date:  1988-10
View more
  35 in total

1.  Asymmetrical hip bone density in multiple sclerosis.

Authors:  Rebecca D Larson; Lesley J White
Journal:  Int J MS Care       Date:  2011

2.  Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.

Authors:  Stine Marit Moen; Elisabeth Gulowsen Celius; Leiv Sandvik; Magritt Brustad; Lars Nordsletten; Erik Fink Eriksen; Trygve Holmøy
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 3.  Bone health in multiple sclerosis.

Authors:  J C Gibson; G D Summers
Journal:  Osteoporos Int       Date:  2011-05-21       Impact factor: 4.507

4.  Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.

Authors:  Carla Roberta Nunes Polachini; Roselia Maria Spanevello; Daniela Zanini; Jucimara Baldissarelli; Luciane Belmonte Pereira; Maria Rosa Chitolina Schetinger; Ivana Beatrice Mânica da Cruz; Charles Elias Assmann; Margarete Dulce Bagatini; Vera Maria Morsch
Journal:  Neurotox Res       Date:  2015-12-21       Impact factor: 3.911

5.  A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.

Authors:  Marloes T Bazelier; Tjeerd-Pieter van Staa; Bernard M J Uitdehaag; Cyrus Cooper; Hubert G M Leufkens; Peter Vestergaard; Joan Bentzen; Frank de Vries
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

6.  Nutritional factors and aging in demyelinating diseases.

Authors:  Ana M Adamo
Journal:  Genes Nutr       Date:  2013-12-06       Impact factor: 5.523

Review 7.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Vitamin D and Anaesthesia.

Authors:  Ebru Biricik; Yasemin Güneş
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

10.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Authors:  Sarah-Michelle Orton; Andrew P Morris; Blanca M Herrera; Sreeram V Ramagopalan; Matthew R Lincoln; Michael J Chao; Reinhold Vieth; A Dessa Sadovnick; George C Ebers
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.